Histologically Proven Extranodal NKTcell Lymphoma
1 clinical trials · Condition
◉ Watch Histologically Proven Extranodal NKTcell Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell Lymphoma (NCT01913119) | Samsung Medical Center | 2013-07-01 |
Track Histologically Proven Extranodal NKTcell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.